Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
Editor Note: For more information about this release, please scroll to bottom.
LONDON, May 1, 2014 /PRNewswire/ --
On Tuesday, April 29, 2014, the NASDAQ Composite ended at 4,103.54, up 0.72%, the Dow Jones Industrial Average advanced 0.53%, to finish the day at 16,535.37, and the S&P 500 closed at 1,878.33, up 0.48%. The session saw a positive impact from Financials, Information Technology, and Materials sectors along with a drag from Utilities and Consumer Staples sectors. A number of stocks saw large movements, including Wolverine World Wide Inc. (NYSE: WWW), MagneGas Corp. (NASDAQ: MNGA), Sequenom Inc. (NASDAQ: SQNM) and Cubist Pharmaceuticals Inc. (NASDAQ: CBST). Free technical research on WWW, MNGA, SQNM and CBST can be downloaded upon signing up at:
On Tuesday, shares of Wolverine World Wide Inc. fluctuated between $28.25 and $30.00 before ending the session 7.09% higher at $28.38. The stock reported a trading volume of 3.35 million shares, much above its three months average volume of 1.08 million shares. Shares of the company traded at a PE ratio of 20.79. Wolverine World Wide Inc.'s shares have advanced 5.54% in the previous three trading sessions and 0.53% in the last one month, but the stock has lost 16.43% on YTD basis. The S&P 500 Consumer Discretionary Sector Index mapped a gain of 0.40% during the trading session and charted up 1.45% in the last three months. The stock is trading above its 50-day moving average of $27.13. Moreover, shares of Wolverine World Wide Inc. have a Relative Strength Index (RSI) of 41.52. On the same day, Wolverine World Wide Inc. announced its Q1 FY2014 financial results (period ended March 22, 2014). For Q1 FY 2014, the company reported net earnings attributable to Wolverine World Wide Inc. of $37.1 million, or $0.36 per diluted share. Sign up today to read free research on WWW at:
MagneGas Corp.'s stock rallied 15.00%, closing the day at $1.38. The stock recorded a trading volume of 2.35 million shares, compared to its three months average volume of 2.78 million shares. The stock oscillated between $1.20 and $1.45 during the trading session. Over the last one month and the past three months, MagneGas Corp.'s shares have gained 2.22% and 68.29%, respectively. Further, the stock has rallied 213.64% since the start of this year. The S&P 500 Industrials Sector Index registered a gain of 0.25% during the trading session and charted up 5.60% in the previous three months. The stock is trading above its 50-day and 200-day moving averages. MagneGas Corp.'s 50-day moving average of $1.22 is above its 200-day moving average of $0.83. Additionally, the stock has an RSI of 42.81. On the same day, MagneGas Corp. announced its first customer order by Sidney Lee Welding Inc. of Georgia. Sidney Lee purchased $10,000 of MagneGas's fuel, which amounted to approximately an entire semi-truck of cylinders. Sign up today to read free research on MNGA at:
On Tuesday, Sequenom Inc.'s stock recorded a trading volume of 3.03 million shares, higher than its three months average volume of 1.77 million shares. The stock ended the day at $2.73, which was 2.83% above its previous day's closing price of $2.65, and registered an intraday range of $2.63 and $2.85. Sequenom Inc.'s shares have lost 0.55% in the previous three trading sessions. However, the company's shares have gained 14.50% in the last one month and 16.45% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 0.62% during the trading session and charted up 4.72% in the previous three months. Sequenom Inc.'s stock is trading above its 50-day and 200-day moving averages of $2.45 and $2.63, respectively. Furthermore, shares of the company have an RSI of 56.53. Sign up today to read free research on SQNM at:
Shares of Cubist Pharmaceuticals Inc. finished Tuesday's session 12.52% higher at $70.11. A total of 2.56 million shares were traded, which was above its three months average volume of 0.92 million shares. The stock vacillated between $64.77 and $70.16 during the session. Over the previous three trading session and the last one month, Cubist Pharmaceuticals Inc.'s shares have advanced 5.41% and 0.01%, respectively. Additionally, from the year's start, the company's stock has gained an upside of 1.80%. The S&P 500 Health Care Sector Index mapped a gain of 0.48% in the previous three trading session and charted up 0.52% in the last one month. The company's shares are trading above its 200-day moving average. Moreover, the stock's 50-day moving average of $72.90 is greater than its 200-day moving average of $67.01. Cubist Pharmaceuticals Inc.'s stock traded at a PE ratio of 62.86 and has an RSI of 36.30. Sign up today to read free research on CBST at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
©2012 PR Newswire. All Rights Reserved.